Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30. GIC ...

Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug ...

The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity ...

Novotech provides biotech to small and mid-sized pharma companies. GIC and Temasek have signed a binding agreement to acquire ...

Temasek Holdings Pte and GIC Pte Ltd. will acquire a significant stake in Novotech Pty Ltd. to fuel growth and accelerate ...

Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations ...

Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a ...

SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a ...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma ...

Temasek and GIC will acquire a significant stake in Novotech, whose ebitda has grown fivefold since TPG’s initial investment ...

Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that ...